CVS Health (CVS) Q1 results:
Revenues: $66,755M (+8.3%); Pharmacy Services:
$34,983M (+4.2%); Retail/LTC: $22,749M (+7.7%); Healthcare Benefits:
$19,198M (+7.4%).
Net Income: $2,012M (+41.0%); EPS: $1.53 (+40.4%); non-GAAP Net Income: $2,502M (+18.9%); non-GAAP EPS: $1.91 (+17.9%).
CF Ops: $3,305M (+69.7%).
Pharmacy claims processed: 541.4M (+59.6%).
Pharmacy Services Generic dispensing rate of 89.0% vs. 88.3% in Q1 2019.
Retail Prescription volume up 9.8%; Generic dispensing rate 89.3% vs. 88.7% a year ago.
Medical membership 23.5M vs. 22.8M in Q1 2019.
2020 Guidance: EPS: $5.47 – 5.60 (unch); non-GAAP EPS: $7.04 – 7.17 (unch); cash flow ops: $10.5B – 11.0B (unch).
Shares are up 4% premarket.
Previously: CVS Health EPS beats by $0.28, beats on revenue (May 6)
https://seekingalpha.com/news/3569933-cvs-health-up-4-premarket-on-q1-beat-guidance-affirmed
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.